How To Calculate Lung Shunt Fraction

Estimate lung shunt fraction (LSF) from Tc-99m MAA counts with optional background correction and lung dose estimation.

How to Calculate Lung Shunt Fraction: Expert Clinical Guide

Lung shunt fraction (LSF) is one of the most important safety parameters in hepatic radioembolization planning. In practical terms, it estimates what fraction of particles could bypass the hepatic microcirculation and pass to the lungs. If the shunt is higher than expected, the radiation dose delivered to lung tissue can become clinically significant and may increase the risk of radiation pneumonitis. Because of this, careful LSF estimation is a core part of pre-treatment workup, especially for Y-90 therapy planning in patients with hepatocellular carcinoma (HCC), cholangiocarcinoma, or liver-dominant metastases.

Most centers calculate LSF using Tc-99m macroaggregated albumin (MAA) imaging after angiographic simulation. The simple and widely used equation is: LSF = Lung counts / (Lung counts + Liver counts). This can be reported as a decimal (0.08) or percentage (8%). In many workflows, counts may be corrected for background activity before final LSF reporting. The calculator above supports both raw-count and background-corrected methods.

Why Lung Shunt Fraction Matters

• It helps estimate lung absorbed dose before Y-90 treatment.
• It informs whether activity reduction is needed for safer delivery.
• It helps identify patients with elevated hepatopulmonary shunting risk.
• It contributes to multidisciplinary treatment planning and informed consent.

If you want primary references, start with evidence summaries and reviews hosted by the U.S. National Library of Medicine: NIH StatPearls overview on radioembolization, a focused review discussing dosimetry and safety considerations available at PubMed Central, and continuously updated indexed literature via PubMed search for lung shunt fraction in radioembolization.

Core Formula and Step by Step Workflow

1. Obtain Tc-99m MAA planar or SPECT/CT imaging after simulation angiography.
2. Draw standardized lung and liver regions of interest (ROIs).
3. Record total counts in each ROI.
4. If your protocol requires it, apply background correction using ROI area and background counts per pixel.
5. Calculate LSF with corrected counts:
   LSF (%) = 100 x [Corrected Lung Counts / (Corrected Lung Counts + Corrected Liver Counts)].
6. If treatment activity is known, estimate lung absorbed dose with a local validated formula and device-specific protocol.

Background Correction: When and How

Background correction is used to reduce overestimation from non-target scattered counts and physiologic background activity. In one common approach:

• Background counts per pixel = Background ROI Counts / Background ROI Pixels
• Corrected lung counts = Raw lung counts – (Background counts per pixel x Lung ROI pixels)
• Corrected liver counts = Raw liver counts – (Background counts per pixel x Liver ROI pixels)

If corrected counts are zero or negative, review ROI placement, acquisition quality, and attenuation factors. Invalid corrected counts usually indicate technical mismatch rather than biologic reality.

Example Calculation

Assume raw lung counts are 150,000 and raw liver counts are 1,850,000. Using the basic method:

LSF = 150,000 / (150,000 + 1,850,000) = 150,000 / 2,000,000 = 0.075 = 7.5%.

If planned activity is 1.8 GBq and estimated lung mass is 1.0 kg, a simplified dose estimate is: Lung dose ≈ 1.8 x 0.075 x 50 / 1.0 = 6.75 Gy. Your center may use more detailed dosimetry methods, but this gives a fast screening estimate.

Comparison Table: Typical Reported LSF Ranges in Clinical Practice

Tumor Setting	Typical Median LSF Range	Common Clinical Interpretation
Hepatocellular carcinoma (HCC)	About 5% to 9%	Most patients are within accepted safety windows; elevated values need dose adjustment
Colorectal liver metastases	About 3% to 7%	Often lower shunting than advanced infiltrative HCC presentations
Neuroendocrine liver metastases	About 2% to 6%	Generally favorable for standard planning in many cohorts

Clinical note: exact distributions vary by disease burden, vascularity, angiographic technique, and imaging protocol. Always use institutional standards and multidisciplinary review for final treatment decisions.

Safety Thresholds and Dose Guardrails

Historically, many programs used direct LSF cutoffs for activity reduction or treatment exclusion. Modern approaches increasingly rely on personalized dosimetry, but traditional guardrails are still widely referenced, especially in initial planning and quality checks.

Planning Parameter	Frequently Used Benchmark	Practical Implication
LSF low range	Less than 10%	Usually compatible with standard planning in many protocols
LSF moderate range	10% to 20%	Often prompts activity optimization and careful lung dose review
LSF high range	Greater than 20%	May require significant activity reduction or alternate strategy based on policy
Estimated lung dose, single session	Commonly kept below about 30 Gy in many modern protocols	Aims to reduce pneumonitis risk
Estimated cumulative lung dose	Commonly kept below about 50 Gy in repeat treatment settings	Used as an added longitudinal safety check

Sources of Error in LSF Calculation

• ROI inconsistency: Different operators may contour lungs or liver differently, especially near diaphragmatic edges.
• Planar overlap artifacts: Planar imaging can misattribute counts if activity projection is complex.
• Tumor biology mismatch: Tc-99m MAA is a surrogate for microsphere distribution and not a perfect one-to-one model.
• Attenuation and scatter: If corrections are omitted or inconsistent, LSF may be biased.
• Timing and catheter position variation: Differences between simulation and treatment catheter position can alter real flow behavior.

Planar vs SPECT/CT Based Approaches

Planar methods remain common because they are fast, available, and historically validated. However, SPECT/CT based quantification can improve anatomic localization and reduce some overlap uncertainty. In centers that routinely use SPECT/CT dosimetry pipelines, LSF calculation may integrate attenuation corrected volumes and voxel dosimetry. Even so, many treatment decision pathways still include a planar-compatible LSF benchmark for consistency with established guidelines and institutional experience.

How to Interpret Results in a Clinical Workflow

1. Confirm technical quality: injection quality, angiographic position, and image adequacy.
2. Check LSF value against institutional policy thresholds.
3. If planned activity is known, estimate lung dose and compare to your safety limits.
4. If risk appears high, consider reduced activity, lobar staging, segmental strategy, or alternate therapy.
5. Document assumptions, correction method, and formula used in the report.

Quick Clinical Interpretation Bands

• LSF less than 10%: Usually favorable from a lung safety perspective.
• LSF 10% to 20%: Intermediate zone where activity tailoring is commonly important.
• LSF above 20%: High caution zone; often requires protocol-driven modification or deferral.

Best Practices for Accurate Reporting

• Use a standardized naming template for ROI sets and correction settings.
• Report raw counts and corrected counts to keep calculations auditable.
• State whether planar, SPECT/CT, or hybrid methodology was used.
• Include estimated lung dose only with clearly documented assumptions.
• Track outcomes against baseline LSF over time to improve local protocol quality.

Final Takeaway

Calculating lung shunt fraction is straightforward mathematically but clinically high-impact. A robust approach combines correct formula use, consistent imaging technique, disciplined ROI practice, and dose-aware interpretation. The calculator on this page is designed to support that workflow: it lets you perform raw or background-corrected LSF estimation, convert activity units, and generate a quick lung dose estimate with visual feedback. Use it as a practical planning aid, then finalize decisions within your institution’s validated dosimetry protocol and multidisciplinary review framework.